BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34952595)

  • 21. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
    Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
    Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of intratumoral natural killer cells in gastric carcinoma.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Che X; Iwashige H; Aridome K; Hokita S; Aikou T
    Cancer; 2000 Feb; 88(3):577-83. PubMed ID: 10649250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
    Kamiya T; Seow SV; Wong D; Robinson M; Campana D
    J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping and Characterization of HCMV-Specific Unconventional HLA-E-Restricted CD8 T Cell Populations and Associated NK and T Cell Responses Using HLA/Peptide Tetramers and Spectral Flow Cytometry.
    Rousselière A; Delbos L; Bressollette C; Berthaume M; Charreau B
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing Natural Killer and CD8
    Ravindranath MH; Filippone EJ; Devarajan A; Asgharzadeh S
    Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):38-59. PubMed ID: 31009335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of CD57+ natural killer cells and CD8+ T lymphocytes in periapical granulomas and radicular cysts.
    Silva LABD; Sá MAR; Melo RA; Pereira JDS; Silveira ÉJDD; Miguel MCDC
    Braz Oral Res; 2017 Dec; 31():e106. PubMed ID: 29267667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
    Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
    Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cells and ILCs in tumor immunotherapy.
    Sivori S; Pende D; Quatrini L; Pietra G; Della Chiesa M; Vacca P; Tumino N; Moretta F; Mingari MC; Locatelli F; Moretta L
    Mol Aspects Med; 2021 Aug; 80():100870. PubMed ID: 32800530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
    Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
    Front Immunol; 2020; 11():1231. PubMed ID: 32625211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD16
    Frazao A; Messaoudene M; Nunez N; Dulphy N; Roussin F; Sedlik C; Zitvogel L; Piaggio E; Toubert A; Caignard A
    Cancer Immunol Res; 2019 Feb; 7(2):208-218. PubMed ID: 30514793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of age and CMV on NK cell subpopulations.
    Campos C; Pera A; Sanchez-Correa B; Alonso C; Lopez-Fernandez I; Morgado S; Tarazona R; Solana R
    Exp Gerontol; 2014 Jun; 54():130-7. PubMed ID: 24440462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Favorable prognostic impact of Natural Killer cells and T cells in high-grade serous ovarian carcinoma.
    Henriksen JR; Donskov F; Waldstrøm M; Jakobsen A; Hjortkjaer M; Petersen CB; Dahl Steffensen K
    Acta Oncol; 2020 Jun; 59(6):652-659. PubMed ID: 31931651
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential activation of CD57-defined natural killer cell subsets during recall responses to vaccine antigens.
    White MJ; Nielsen CM; McGregor RH; Riley EH; Goodier MR
    Immunology; 2014 May; 142(1):140-50. PubMed ID: 24843874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of natural killer cell (CD57) as a prognostic marker in oral squamous cell carcinoma: An immunohistochemistry study.
    Agarwal R; Chaudhary M; Bohra S; Bajaj S
    J Oral Maxillofac Pathol; 2016; 20(2):173-7. PubMed ID: 27601804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological significance and prognostic roles of densities of CD57+ cells, CD68+ cells, and mast cells, and their ratios in clear cell renal cell carcinoma.
    Nakanishi H; Miyata Y; Mochizuki Y; Yasuda T; Nakamura Y; Araki K; Sagara Y; Matsuo T; Ohba K; Sakai H
    Hum Pathol; 2018 Sep; 79():102-108. PubMed ID: 29787818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and function of killer immunologublin receptor and CD57 of natural killer cells].
    Zhao XY; Zhao XS; Wang YZ; Chang YJ; Lv M; Wang HT; Han TT; Huang XJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Feb; 46(1):115-9. PubMed ID: 24535362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
    Davis ZB; Cogswell A; Scott H; Mertsching A; Boucau J; Wambua D; Le Gall S; Planelles V; Campbell KS; Barker E
    PLoS Pathog; 2016 Feb; 12(2):e1005421. PubMed ID: 26828202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.
    Bonorino P; Ramzan M; Camous X; Dufeu-Duchesne T; Thélu MA; Sturm N; Dariz A; Guillermet C; Pernollet M; Zarski JP; Marche PN; Leroy V; Jouvin-Marche E
    J Hepatol; 2009 Sep; 51(3):458-67. PubMed ID: 19596474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.